No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Formycon and Teva Join Forces on Ustekinumab Biosimilar in Germany
On 26 June 2025, Formycon announced that it has entered into a non-exclusive distribution agreement with Teva Group’s subsidiary, Ratiopharm GmbH, to commercialise FYB202/Fymskina®…